AI assistant
Sending…
ANAPTYSBIO, INC — Director's Dealing 2017
Mar 1, 2017
32596_dirs_2017-02-28_676683bb-427a-46cc-866e-86b24db53416.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANAPTYSBIO INC (ANAB)
CIK: 0001370053
Period of Report: 2017-02-24
Reporting Person: Schoeneck James A (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-02-24 | Director Stock Option (right to buy) | $24.60 | A | 15000 | Acquired | 2027-02-23 | Common Stock (15000) | Direct |
Footnotes
F1: The stock option vests and becomes fully exercisable on February 24, 2018.
More from ANAPTYSBIO, INC
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 21
Regulatory Filings
2026
Apr 20
Director's Dealing
2026
Mar 28
Regulatory Filings
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 3
Regulatory Filings
2026
Mar 3
Director's Dealing
2026
Feb 13
Major Shareholding Notification
2026
Jan 16